IBDEI11I ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16903,2)
 ;;=^5014521
 ;;^UTILITY(U,$J,358.3,16904,0)
 ;;=M86.00^^61^777^60
 ;;^UTILITY(U,$J,358.3,16904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16904,1,3,0)
 ;;=3^Osteomyelitis,Acute Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,16904,1,4,0)
 ;;=4^M86.00
 ;;^UTILITY(U,$J,358.3,16904,2)
 ;;=^5014497
 ;;^UTILITY(U,$J,358.3,16905,0)
 ;;=M86.50^^61^777^62
 ;;^UTILITY(U,$J,358.3,16905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16905,1,3,0)
 ;;=3^Osteomyelitis,Chronic Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,16905,1,4,0)
 ;;=4^M86.50
 ;;^UTILITY(U,$J,358.3,16905,2)
 ;;=^5014607
 ;;^UTILITY(U,$J,358.3,16906,0)
 ;;=M86.30^^61^777^63
 ;;^UTILITY(U,$J,358.3,16906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16906,1,3,0)
 ;;=3^Osteomyelitis,Chronic Multifocal,Unspec Site
 ;;^UTILITY(U,$J,358.3,16906,1,4,0)
 ;;=4^M86.30
 ;;^UTILITY(U,$J,358.3,16906,2)
 ;;=^5014559
 ;;^UTILITY(U,$J,358.3,16907,0)
 ;;=M86.8X9^^61^777^66
 ;;^UTILITY(U,$J,358.3,16907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16907,1,3,0)
 ;;=3^Osteomyelitis,Unspec Sites
 ;;^UTILITY(U,$J,358.3,16907,1,4,0)
 ;;=4^M86.8X9
 ;;^UTILITY(U,$J,358.3,16907,2)
 ;;=^5014655
 ;;^UTILITY(U,$J,358.3,16908,0)
 ;;=M86.60^^61^777^64
 ;;^UTILITY(U,$J,358.3,16908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16908,1,3,0)
 ;;=3^Osteomyelitis,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,16908,1,4,0)
 ;;=4^M86.60
 ;;^UTILITY(U,$J,358.3,16908,2)
 ;;=^5014630
 ;;^UTILITY(U,$J,358.3,16909,0)
 ;;=M86.40^^61^777^59
 ;;^UTILITY(U,$J,358.3,16909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16909,1,3,0)
 ;;=3^Osteomyelitis w/ Draining Sinus,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,16909,1,4,0)
 ;;=4^M86.40
 ;;^UTILITY(U,$J,358.3,16909,2)
 ;;=^5014583
 ;;^UTILITY(U,$J,358.3,16910,0)
 ;;=R50.2^^61^777^26
 ;;^UTILITY(U,$J,358.3,16910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16910,1,3,0)
 ;;=3^Fever,Drug-Induced
 ;;^UTILITY(U,$J,358.3,16910,1,4,0)
 ;;=4^R50.2
 ;;^UTILITY(U,$J,358.3,16910,2)
 ;;=^5019507
 ;;^UTILITY(U,$J,358.3,16911,0)
 ;;=R50.9^^61^777^30
 ;;^UTILITY(U,$J,358.3,16911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16911,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,16911,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,16911,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,16912,0)
 ;;=R76.11^^61^777^1
 ;;^UTILITY(U,$J,358.3,16912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16912,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,16912,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,16912,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,16913,0)
 ;;=Z21.^^61^777^33
 ;;^UTILITY(U,$J,358.3,16913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16913,1,3,0)
 ;;=3^HIV Asymptomatic,Infection Status
 ;;^UTILITY(U,$J,358.3,16913,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,16913,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,16914,0)
 ;;=B37.0^^61^777^18
 ;;^UTILITY(U,$J,358.3,16914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16914,1,3,0)
 ;;=3^Candidal Stomatitis (Oral Thrush)
 ;;^UTILITY(U,$J,358.3,16914,1,4,0)
 ;;=4^B37.0
 ;;^UTILITY(U,$J,358.3,16914,2)
 ;;=^5000612
 ;;^UTILITY(U,$J,358.3,16915,0)
 ;;=B97.10^^61^777^25
 ;;^UTILITY(U,$J,358.3,16915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16915,1,3,0)
 ;;=3^Enterovirus,Unspec,as Cause of Disease
 ;;^UTILITY(U,$J,358.3,16915,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,16915,2)
 ;;=^5000861
